Literature DB >> 21388742

Common pathogens in burn wound and changes in their drug sensitivity.

Ezzatollah Rezaei1, Hosain Safari, Mahbobe Naderinasab, Hassan Aliakbarian.   

Abstract

Infection is an important cause of mortality in patients with burns. Rapid emergence of hospital pathogens and antibiotic-resistant organisms necessitate periodic evaluation of bacterial colonisation patterns and antibiogram sensitivity in burn wards. In this study, which was conducted in a 3 months' period in 2009, 106 samples from the wounds of 59 patients admitted in a burn ward were taken, one in the 1st and one between the 3rd and the 7th days. Pseudomonas aeruginosa, Acinetobacter and Klebsiella were the most common Gram-negative and Staphylococcus aureus was the most common Gram-positive organisms recovered from the patients. This study showed a high rate of resistance to the administered antibiotics. The prevalent Gram-negative organisms in our ward were resistant to ceftazidime and imipenem in nearly 90% and 20% of cases, respectively.
Copyright © 2011 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388742     DOI: 10.1016/j.burns.2011.01.019

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  33 in total

1.  Next-Generation Sequencing and Comparative Analysis of Sequential Outbreaks Caused by Multidrug-Resistant Acinetobacter baumannii at a Large Academic Burn Center.

Authors:  Hajime Kanamori; Christian M Parobek; David J Weber; David van Duin; William A Rutala; Bruce A Cairns; Jonathan J Juliano
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

2.  Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mohammad Savari; Effat Abbasi Montazeri; Saeed Khoshnood
Journal:  Pathog Glob Health       Date:  2020-06-19       Impact factor: 2.894

3.  Population pharmacokinetic analysis of piperacillin in burn patients.

Authors:  Sangil Jeon; Seunghoon Han; Jongtae Lee; Taegon Hong; Jeongki Paek; Heungjeong Woo; Dong-Seok Yim
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

4.  Development of rapid phenotypic system for the identification of Gram-negative oxidase-positive bacilli in resource-limited settings.

Authors:  Mahmooda Kazmi; Adnan Khan; Shahana Urooj Kazmi
Journal:  J Biosci       Date:  2013-06       Impact factor: 1.826

5.  Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Authors:  Tricia A Van Laar; Tsute Chen; Tao You; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

6.  Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital.

Authors:  Yali Gong; Xiaodong Shen; Guangtao Huang; Cheng Zhang; Xiaoqiang Luo; Supeng Yin; Jing Wang; Fuquan Hu; Yizhi Peng; Ming Li
Journal:  J Microbiol       Date:  2016-08-02       Impact factor: 3.422

7.  Nosocomial infections among burn patients in Teheran, Iran: a decade later.

Authors:  R Alaghehbandan; L Azimi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

8.  H2S, a Bacterial Defense Mechanism against the Host Immune Response.

Authors:  Tracy Toliver-Kinsky; Weihua Cui; Gabor Törö; Seung-Jin Lee; Konstantin Shatalin; Evgeny Nudler; Csaba Szabo
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

9.  Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China.

Authors:  Hanghui Cen; Zhenbo Wu; Fan Wang; Chunmao Han
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  MrkD1P from Klebsiella pneumoniae strain IA565 allows for coexistence with Pseudomonas aeruginosa and protection from protease-mediated biofilm detachment.

Authors:  Brandon M Childers; Tricia A Van Laar; Tao You; Steven Clegg; Kai P Leung
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.